Navigation Links
Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
Date:3/2/2011

SAN DIEGO, March 2, 2011 /PRNewswire/ -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.

The VerifyNow System is widely used by practicing physicians to assess patients' platelet response to various antiplatelet therapies already available on the market, such as aspirin, P2Y12 inhibitors (e.g. Plavix® and Effient®)and GP IIb/IIIa inhibitors. The VerifyNow System is also a frequently used tool of clinical researchers to measure the antiplatelet effect of drugs in development.  By incorporating the VerifyNow System in pharmaceutical clinical trials, data are generated to support the integration of platelet reactivity testing in the patient care pathway as new agents are introduced to the market.

"With the signing of this agreement, Accumetrics is solidifying its role as a premier partner of pharmaceutical companies in the development and validation of new and emerging antiplatelet drugs," said Timothy I. Still, President and CEO of Accumetrics.  "With the trend towards individualized and targeted approaches to treating patients, the VerifyNow System plays an important role at both the commercial and development ends of the spectrum."

The VerifyNow System is widely used in various clinical settings where antiplatelet medications are prescribed to reduce the occurrence of future thrombotic events such as heart attack and stroke.

About Accumetrics Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for ra
'/>"/>

SOURCE Accumetrics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Accumetrics Closes 2010 With Positive Outlook
2. Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
3. Accumetrics Closes 2009 with Positive Outlook
4. Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference
5. Accumetrics Announces $16.5M in New Capital Financing
6. Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
7. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
8. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
9. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
10. Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
11. Royal Fornia Electronic Device Co., Ltd. Signs Technology Licensing Agreement to Integrate Masimo rainbow SET Pulse CO-Oximetry Into New Patient Monitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  BioPharmX Corporation (OTCQB: BPMX), ... of novel drug delivery products to address unmet ... announced the appointment of Stephen Morlock , ... to its board of directors.  Mr. Morlock,s background ... expand its national roll-out of Violet iodine, the ...
(Date:3/30/2015)... 30, 2015 Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid ... Obama for establishing a National Action Plan with ... threat of antibiotic resistance. We look forward to continuing ...
(Date:3/30/2015)... 30, 2015 Beta-O2 ... as the company,s new chief executive officer. Dr. ... leading early stage Israeli venture capital firm. He is ... and vascular surgery.        (Logo: http://photos.prnewswire.com/prnh/20140910/705638) ... Sherpa Innoventures is Beta-O2,s newest investor, having participated in ...
Breaking Medicine Technology:BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
... Legal-Bay LLC, through its website lawsuitssettlementfunding.com ... to plaintiffs in need of lawsuit cash advances ... an industry leader; however they are striving to set ... company announced that they have ramped up their operations ...
... Assured Pharmacy (Pink Sheets: APHYD ), a ... than 3,000 sufferers of chronic pain, is pleased to ... completed an audit of Assured Pharmacy,s consolidated financial statements ... financial statements have been posted on the OTC Markets ...
Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Assured Pharmacy Completes Audit of 2010 Financial Statements 2
(Date:3/30/2015)... March 30, 2015 A new Zofran ... California Superior Court on behalf of a child who ... after his mother was prescribed the anti-nausea medication during ... 6th filing in Alameda Superior Court, the baby’s mother ... that she experienced in the early months of her ...
(Date:3/30/2015)... “ iCareTech ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... technology expert, conducted the review and shared with viewers how ... the medical and health fields. , Wearable technology has been ... past couple of years. Well, at CES, NewsWatch TV came ...
(Date:3/30/2015)... 30, 2015 A key protein previously ... plays an important role in the response to viral ... the Icahn School of Medicine at Mount Sinai published ... long been associated with inflammation, part of the body’s ... cells home in to attack invaders like bacteria and ...
(Date:3/30/2015)... 2015 On March 29, 2015 the United ... honor of all small business owners, for their commitment to ... , According to Zane Benefits' website, small businesses in ... 75% of all jobs and employing over 60 million people. ... of all U.S. sales. The small business sector is growing ...
(Date:3/30/2015)... 2015 Tel-Aviv – March 30, 2015 ... announced the closing of $12.5 million in new financing ... Viola Group. The funding will further GlassesUSA's aggressive business ... in the growing global market of online eyewear, both ... by CEO Daniel Rothman, COO Eldad Rothman, and CTO ...
Breaking Medicine News(10 mins):Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... RONKONKOMA, N.Y., April 24 NBTY, Inc. (NYSE:,NTY) ... supplements, today announced results for the fiscal second,quarter and ... the fiscal second quarter ended March 31, 2008, net ... fiscal second quarter ended March,31, 2007, an increase of ...
... strengthen KePRO,s corporate infrastructure and provide ... tactical and strategic market advantages, ... Inc. (KePRO), a rapidly growing, national medical management,firm has ... senior positions. Meghan Harris, MS, is KePRO,s new Vice,President, ...
... The following are,excerpts from an article in The ... Republican National Committee:, Congressional Democrats are backing away ... saying that even if,their party controls the White House ... some senators, the promises made by Sens. Barack Obama ...
... April 24 ,The U.S. Food and Drug Administration ... Actonel(R) (risedronate sodium) tablets for the treatment,and prevention ... risk of fractures in postmenopausal women with osteoporosis., ... is based on a study comparing,Actonel 150 mg ...
... The Perrigo Company,(Nasdaq: PRGO ; TASE) today ... and Drug Administration (FDA) to market over-the-counter (OTC),Nicotine Polacrilex ... (Orange, Coated)., The FDA has determined the product ... Gum, 2 mg (base) and 4 mg,(base), which is ...
... Two ... Days of FDA Approval, ... of its,CIMplicity(TM) program, designed to enhance treatment support for patients,suffering ... their caregivers with comprehensive financial,administrative, compliance and treatment support. The ...
Cached Medicine News:Health News:NBTY Reports Second Quarter Results 2Health News:NBTY Reports Second Quarter Results 3Health News:NBTY Reports Second Quarter Results 4Health News:NBTY Reports Second Quarter Results 5Health News:NBTY Reports Second Quarter Results 6Health News:NBTY Reports Second Quarter Results 7Health News:NBTY Reports Second Quarter Results 8Health News:NBTY Reports Second Quarter Results 9Health News:NBTY Reports Second Quarter Results 10Health News:NBTY Reports Second Quarter Results 11Health News:NBTY Reports Second Quarter Results 12Health News:NBTY Reports Second Quarter Results 13Health News:NBTY Reports Second Quarter Results 14Health News:NBTY Reports Second Quarter Results 15Health News:NBTY Reports Second Quarter Results 16Health News:NBTY Reports Second Quarter Results 17Health News:NBTY Reports Second Quarter Results 18Health News:KePRO Appoints Two New IT Vice Presidents 2Health News:KePRO Appoints Two New IT Vice Presidents 3Health News:RNC: Dems Hedge on Healthcare 2Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 2Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 3Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 4Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 5Health News:Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum 2Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 2Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 3Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 4Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 5Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 6Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 7
... Anatomical Malar I Implants - Providing the ... follows the contour of the zygoma while ... Anatomical Malar II Implants - The ... surgeon with another augumentation option that adds ...
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... Thermos IEC CL31 Multispeed Series ... in a quiet, compact, 1.2 liter ... of rotors and accessories and high-speed ... offers virtually everything you need to ...
Medicine Products: